Encellin fetches $5.9m seed

Encellin, a personalized regenerative medicine biotech company, has secured $5.9 million in seed financing.

Encellin, a personalized regenerative medicine biotech company, has secured $5.9 million in seed financing. Khosla Ventures and SV Latam Capital led the round with participation from Sandhill Angels and Y Combinator.

Source: Press Release